These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 8052966

  • 1. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
    Kobayashi H, Gotoh J, Shinohara H, Moniwa N, Terao T.
    Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse.
    Ossowski L, Russo-Payne H, Wilson EL.
    Cancer Res; 1991 Jan 01; 51(1):274-81. PubMed ID: 1988089
    [Abstract] [Full Text] [Related]

  • 4. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 5. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR, Tang J, Hu G, Lin Y, Mutter W, Tong C, Karumanchi SA, Russell SJ, Sukhatme VP.
    J Natl Cancer Inst; 2006 Jun 07; 98(11):756-64. PubMed ID: 16757700
    [Abstract] [Full Text] [Related]

  • 6. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
    Todaro LB, Ladeda V, Bal de Kier Joffé E, Farías EF.
    Oncol Rep; 2003 Jun 07; 10(3):725-32. PubMed ID: 12684650
    [Abstract] [Full Text] [Related]

  • 7. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
    Mitra SK, Lim ST, Chi A, Schlaepfer DD.
    Oncogene; 2006 Jul 27; 25(32):4429-40. PubMed ID: 16547501
    [Abstract] [Full Text] [Related]

  • 8. Tumor invasion-inhibiting factor 2: primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells.
    Isoai A, Giga-Hama Y, Shinkai K, Mukai M, Akedo H, Kumagai H.
    Cancer Res; 1992 Mar 15; 52(6):1422-6. PubMed ID: 1311631
    [Abstract] [Full Text] [Related]

  • 9. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gänsbacher B, Schmitt M.
    Cancer Gene Ther; 2000 Feb 15; 7(2):292-9. PubMed ID: 10770639
    [Abstract] [Full Text] [Related]

  • 10. The antibody to plasminogen activator inhibitor-1 suppresses pulmonary metastases of human fibrosarcoma in athymic mice.
    Tsuchiya H, Katsuo S, Matsuda E, Sunayama C, Tomita K, Ueda Y, Binder BR.
    Gen Diagn Pathol; 1995 May 15; 141(1):41-8. PubMed ID: 8542506
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model.
    Kobayashi H, Gotoh J, Fujie M, Shinohara H, Moniwa N, Terao T.
    Int J Cancer; 1994 Jun 01; 57(5):727-33. PubMed ID: 8194882
    [Abstract] [Full Text] [Related]

  • 12. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
    Yu HR, Schultz RM.
    Cancer Res; 1990 Dec 01; 50(23):7623-33. PubMed ID: 1701350
    [Abstract] [Full Text] [Related]

  • 13. Suppressing effects of dietary supplementation of soybean trypsin inhibitor on spontaneous, experimental and peritoneal disseminated metastasis in mouse model.
    Kobayashi H, Fukuda Y, Yoshida R, Kanada Y, Nishiyama S, Suzuki M, Kanayama N, Terao T.
    Int J Cancer; 2004 Nov 10; 112(3):519-24. PubMed ID: 15382080
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models.
    Kobayashi H, Shinohara H, Fujie M, Gotoh J, Itoh M, Takeuchi K, Terao T.
    Int J Cancer; 1995 Nov 03; 63(3):455-62. PubMed ID: 7591248
    [Abstract] [Full Text] [Related]

  • 15. Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.
    Datta A, Kitson RP, Xue Y, al-Atrash G, Mazar AP, Jones TR, Goldfarb RH.
    In Vivo; 2002 Nov 03; 16(6):451-7. PubMed ID: 12494889
    [Abstract] [Full Text] [Related]

  • 16. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R, Biliran H, Sager R, Sheng S.
    Cancer Res; 2000 Sep 01; 60(17):4771-8. PubMed ID: 10987285
    [Abstract] [Full Text] [Related]

  • 17. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
    Frandsen TL, Holst-Hansen C, Nielsen BS, Christensen IJ, Nyengaard JR, Carmeliet P, Brünner N.
    Cancer Res; 2001 Jan 15; 61(2):532-7. PubMed ID: 11212246
    [Abstract] [Full Text] [Related]

  • 18. No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes.
    Yamamoto Y, Aoyama Y, Shu E, Tsunoda K, Amagai M, Kitajima Y.
    J Dermatol Sci; 2007 Aug 15; 47(2):119-25. PubMed ID: 17532189
    [Abstract] [Full Text] [Related]

  • 19. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA, Gladu J.
    Cancer Res; 2002 Apr 15; 62(8):2390-7. PubMed ID: 11956102
    [Abstract] [Full Text] [Related]

  • 20. Urokinase plasminogen activator is necessary but not sufficient for prostate cancer cell invasion.
    Jarrard DF, Hansen NM, Patai B, Rukstalis DB.
    Invasion Metastasis; 1995 Apr 15; 15(1-2):34-45. PubMed ID: 7672930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.